Bai Yun, Xu Liang, Yang Xiaobo, Hu Zhibin, Yuan Jing, Wang Feng, Shao Minhua, Yuan Wentao, Qian Ji, Ma Hongxia, Wang Ying, Liu Hongliang, Chen Weihong, Yang Lin, Jing Guangfu, Huo Xiang, Chen Feng, Liu Yanhong, Jin Li, Wei Qingyi, Huang Wei, Shen Hongbing, Lu Daru, Wu Tangchun
Institute of Occupational Medicine and Ministry of Education Key Lab for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.
BMC Cancer. 2007 May 13;7:81. doi: 10.1186/1471-2407-7-81.
The nucleotide excision repair (NER) protein, xeroderma pigmentosum C (XPC), participates in recognizing DNA lesions and initiating DNA repair in response to DNA damage. Because mutations in XPC cause a high risk of cancer in XP patients, we hypothesized that inherited sequence variations in XPC may alter DNA repair and thus susceptibility to cancer.
In this hospital-based case-control study, we investigated five XPC tagging, common single nucleotide polymorphisms (tagging SNPs) in 1,010 patients with newly diagnosed lung cancer and 1,011 matched cancer free controls in a Chinese population.
In individual tagging SNP analysis, we found that rs3731055AG+AA variant genotypes were associated with a significantly decreased risk of lung adenocarcinoma [adjusted odds ratio (OR), 0.71; 95% confidence interval (CI), 0.56-0.90] but an increased risk of small cell carcinomas [adjusted OR, 1.79; 95% CI, 1.05-3.07]. Furthermore, we found that haplotype ACCCA was associated with a decreased risk of lung adenocarcinoma [OR, 0.78; 95% CI, 0.62-0.97] but an increased risk of small cell carcinomas [OR, 1.68; 95% CI, 1.04-2.71], which reflected the presence of rs3731055A allele in this haplotype. Further stratified analysis revealed that the protective effect of rs3731055AG+AA on risk of lung adenocarcinoma was more evident among young subjects (age < or= 60) and never smokers.
These results suggest that inherited sequence variations in XPC may modulate risk of lung cancer, especially lung adenocarcinoma, in Chinese populations. However, these findings need to be verified in larger confirmatory studies with more comprehensively selected tagging SNPs.
核苷酸切除修复(NER)蛋白,即着色性干皮病C(XPC)蛋白,参与识别DNA损伤并启动针对DNA损伤的DNA修复。由于XPC基因的突变会使着色性干皮病(XP)患者患癌风险升高,我们推测XPC基因的遗传序列变异可能会改变DNA修复能力,进而影响患癌易感性。
在这项基于医院的病例对照研究中,我们在中国人群的1010例新诊断肺癌患者和1011例匹配的无癌对照中,对5个XPC标签单核苷酸多态性(tagging SNPs)进行了研究。
在单个标签单核苷酸多态性分析中,我们发现rs3731055AG + AA变异基因型与肺腺癌风险显著降低相关[校正比值比(OR),0.71;95%置信区间(CI),0.56 - 0.90],但与小细胞癌风险升高相关[校正OR,1.79;95% CI,1.05 - 3.07]。此外,我们发现单倍型ACCCA与肺腺癌风险降低相关[OR,0.78;95% CI,0.62 - 0.97],但与小细胞癌风险升高相关[OR,1.68;95% CI,1.04 - 2.71],这反映了该单倍型中存在rs3731055A等位基因。进一步的分层分析显示,rs3731055AG + AA对肺腺癌风险的保护作用在年轻受试者(年龄≤60岁)和从不吸烟者中更为明显。
这些结果表明,XPC基因的遗传序列变异可能会调节中国人群患肺癌的风险,尤其是肺腺癌。然而,这些发现需要在更全面选择标签单核苷酸多态性的更大规模验证性研究中得到证实。